What’s on the horizon to tackle unmet needs in recurrent metastatic SCCHN?

touchEXPERT OPINIONS for touchONCOLOGY Three experts share insights into the unmet treatment needs for patients with recurrent or metastatic squamous cell carcinoma of the head and neck, the rationale for developing additional immunotherapy-based strategies and targeted therapies, and the latest data and ongoing trials for these investigational approaches.  The experts Dr Aline Chaves - DOM Oncology Group, Divinópolis, Brazil Prof. Makoto Tahara - National Cancer Center Hospital East, Kashiwa, Japan Dr Ranee Mehra - Marlene and Stewart Greenebaum Comprehensive Cancer Center, Baltimore, MD, USA This touchPODCAST is for healthcare professionals outside of the UK only. This activity is funded by an independent medical educational grant from Seagen Inc. and Genmab US, Inc. This activity is jointly provided by USF Health and touchIME. For further information visit our website: https://touchoncologyime.org/future-treatment-of-recurrent-metastatic-scchn/